A detailed history of Rock Springs Capital Management LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 1,250,280 shares of FOLD stock, worth $12 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
1,250,280
Previous 1,218,580 2.6%
Holding current value
$12 Million
Previous $12.1 Million 10.46%
% of portfolio
0.45%
Previous 0.37%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$9.55 - $12.09 $302,735 - $383,253
31,700 Added 2.6%
1,250,280 $13.4 Million
Q2 2024

Aug 14, 2024

BUY
$9.04 - $11.75 $595,952 - $774,607
65,924 Added 5.72%
1,218,580 $12.1 Million
Q1 2024

May 15, 2024

BUY
$11.43 - $14.24 $1.02 Million - $1.27 Million
88,850 Added 8.35%
1,152,656 $13.6 Million
Q4 2022

Feb 14, 2023

BUY
$9.89 - $12.7 $507,357 - $651,510
51,300 Added 5.07%
1,063,806 $13 Million
Q1 2021

May 17, 2021

SELL
$9.2 - $23.86 $151,744 - $393,546
-16,494 Reduced 1.6%
1,012,506 $10 Million
Q4 2020

Feb 16, 2021

BUY
$13.47 - $24.89 $69,761 - $128,905
5,179 Added 0.51%
1,029,000 $23.8 Million
Q3 2020

Nov 16, 2020

BUY
$12.89 - $15.89 $90,230 - $111,230
7,000 Added 0.69%
1,023,821 $14.5 Million
Q2 2020

Aug 14, 2020

BUY
$8.86 - $15.69 $149,034 - $263,921
16,821 Added 1.68%
1,016,821 $15.3 Million
Q1 2018

May 15, 2018

BUY
$13.76 - $17.12 $1.24 Million - $1.54 Million
90,000 Added 9.89%
1,000,000 $15 Million
Q3 2017

Nov 14, 2017

BUY
$11.74 - $15.78 $10.7 Million - $14.4 Million
910,000
910,000 $13.7 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.69B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.